| Health / Medical Topics |
Omapatrilat
A vasopeptidase inhibitor with antihypertensive activity. Omapatrilat exerts its effect by inhibiting angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP). ACE inhibition results in inhibition of the renin-angiotensin-aldosterone system thereby leading to the reduction of vasoconstriction. Inhibition of NEP leads to the inhibition of hydrolyzation of a number of endogenous vasoactive peptides, such as bradykinin and substance P and as NEP is the principal enzyme degrading natriuretic peptides, NEP inhibition also results in an increase in natriuretic peptidase circulation. Ultimately both effects result in blood vessel relaxation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A country in the Middle East, bordering the Arabian Sea, southeast of Saudi Arabia.
A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing…
An acyclic guanosine analog with activity against varicella zoster virus (VZV) and other members of the herpesvirus family. Omaciclovir is selectively phosphorylated…
A drug used to treat certain types of chronic myelogenous leukemia (CML) that have not gotten better after treatment with other…
Spontaneous thyroid carcinoma 33% (Lindsey et al 1968). Adrenal cortical tumors 94% and pituitary tumors 8-18% at 18 months (Hansen et al…
A drug used in cancer prevention.
